Patents by Inventor Allen E. Goodship

Allen E. Goodship has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tissue regrafting
    Patent number: 7108721
    Abstract: The present invention is based on the discovery of new methods for obtaining a tissue graft. The method can be carried out, for example, by implanting a biocompatible scaffold into a mammal and then removing the scaffold from the mammal. The scaffold is implanted in direct contact with (i.e. physically touching over at least a portion of its external surface), or adjacent to (i.e. physically separated from) mature or immature target tissue, for a period of time that is sufficient to allow cells of the target tissue to associate with the scaffold. The invention also features grafts generated by the methods described herein and methods for using those grafts to treat patients who have a defect in a target.
    Type: Grant
    Filed: May 10, 2001
    Date of Patent: September 19, 2006
    Assignee: Massachusetts Institute of Technology
    Inventors: James William Huckle, Melissa Anderson, Allen E. Goodship, Venkatram R. Shastri
  • Certain methanebisphosphonic acid derivatives in fracture healing
    Patent number: 6255288
    Abstract: The invention relates to the use of methanebisphosphonic acid derivatives of formula I for the treatment of fractures. These compounds have surprisingly been found to promote a more rapid and stronger fracture healing in mammals including man.
    Type: Grant
    Filed: November 29, 1993
    Date of Patent: July 3, 2001
    Assignee: Novartis Corporation
    Inventors: Allen E. Goodship, Peter Walker, Donal S. McNally, Timothy J. Chambers, Jonathan Green
  • Use of certain methanebishosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration
    Patent number: 5965547
    Abstract: The invention relates to the use of certain methanebisphosphonic acid derivatives (for the manufacture of a pharmaceutical composition) for the prevention and treatment of prosthesis loosening and prosthesis migration in mammals including man.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: October 12, 1999
    Assignee: Novartis Corporation
    Inventors: Allen E. Goodship, John Kenwright, Jonathan Green